Value Hive Podcast cover image

Q4 2025 Investor Audibles: Laughing Water Capital, Plural Investing, Kathmandu Capital

Value Hive Podcast

00:00

Liquidea: approval, patents, upside

Discussion of Liquidea's Eutrepia launch, patent battles with United Therapeutics, and upside/downside scenarios.

Play episode from 14:37
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app